Free Trial

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

NexGen Energy stock logo

1. NexGen Energy NYSE:NXE

$4.68 -0.01 (-0.11%)
Closing price 03/14/2025 03:59 PM Eastern
Extended Trading
$4.82 +0.13 (+2.77%)
As of 03/14/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NexGen Energy Ltd., an exploration and development stage company, engages in the acquisition, exploration, and evaluation and development of uranium properties in Canada. More about NexGen Energy

Market Capitalization
$2.67 billion
P/E Ratio
31.24
Consensus Rating
Strong Buy
Volume
7.87 million shares
Average Volume
6.32 million shares
Today's Range
$4.63
$4.80
Birchcliff Energy stock logo

2. Birchcliff Energy OTCMKTS:BIREF

$3.99 +0.03 (+0.76%)
As of 03/14/2025 03:59 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.08 billion
P/E Ratio
28.50
Consensus Rating
Strong Buy
Volume
83,219 shares
Average Volume
113,169 shares
Today's Range
$3.97
$4.00
Denison Mines stock logo

3. Denison Mines NYSEAMERICAN:DNN

$1.38 -0.02 (-1.43%)
Closing price 03/14/2025 04:10 PM Eastern
Extended Trading
$1.39 +0.01 (+0.72%)
As of 03/14/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mines

Market Capitalization
$1.24 billion
P/E Ratio
-138.00
Consensus Rating
Strong Buy
Consensus Price Target
$3.00 (+117.4% Upside)
Volume
39.30 million shares
Average Volume
23.90 million shares
Mereo BioPharma Group stock logo

4. Mereo BioPharma Group NASDAQ:MREO

$2.62 +0.12 (+4.80%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$2.62 0.00 (0.00%)
As of 03/14/2025 07:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$387.87 million
Consensus Rating
Buy
Consensus Price Target
$7.83 (+199.0% Upside)
Volume
682,030 shares
Average Volume
1.01 million shares
Today's Range
$2.51
$2.66
Achieve Life Sciences stock logo

5. Achieve Life Sciences NASDAQ:ACHV

$2.76 +0.11 (+4.15%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$2.75 -0.01 (-0.36%)
As of 03/14/2025 05:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. More about Achieve Life Sciences

Market Capitalization
$94.92 million
P/E Ratio
-2.44
Consensus Rating
Buy
Consensus Price Target
$15.75 (+470.7% Upside)
Volume
184,454 shares
Average Volume
254,929 shares
Stardust Power stock logo

6. Stardust Power NASDAQ:SDST

$0.62 +0.02 (+3.49%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$0.60 -0.02 (-3.23%)
As of 03/14/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$32.73 million
Consensus Rating
Buy
Consensus Price Target
$7.94 (+1,180.2% Upside)
Volume
305,944 shares
Average Volume
978,168 shares
Today's Range
$0.55
$0.63
Remove Ads
OnKure Therapeutics stock logo

7. OnKure Therapeutics NASDAQ:OKUR

$4.61 -0.01 (-0.22%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$4.69 +0.08 (+1.82%)
As of 03/14/2025 05:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$15.41 million
P/E Ratio
-0.38
Consensus Rating
Buy
Consensus Price Target
$34.33 (+644.8% Upside)
Volume
39,005 shares
Average Volume
79,294 shares
Bioceres Crop Solutions stock logo

8. Bioceres Crop Solutions NASDAQ:BIOX

$4.63 +0.02 (+0.43%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$4.63 0.00 (0.00%)
As of 03/14/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. More about Bioceres Crop Solutions

Market Capitalization
$290.35 million
P/E Ratio
231.62
Consensus Rating
Buy
Consensus Price Target
$9.88 (+113.3% Upside)
Volume
124,397 shares
Average Volume
149,695 shares
enCore Energy stock logo

9. enCore Energy NASDAQ:EU

$1.45 +0.05 (+3.57%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$1.45 0.00 (0.00%)
As of 03/14/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. More about enCore Energy

Market Capitalization
$260.77 million
P/E Ratio
-5.18
Consensus Rating
Buy
Consensus Price Target
$6.50 (+348.3% Upside)
Volume
1.27 million shares
Average Volume
1.38 million shares
Quince Therapeutics stock logo

10. Quince Therapeutics NASDAQ:QNCX

$1.44 +0.03 (+2.13%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$1.44 0.00 (-0.07%)
As of 03/14/2025 05:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$63.36 million
P/E Ratio
-1.16
Consensus Rating
Buy
Consensus Price Target
$9.50 (+559.7% Upside)
Volume
33,787 shares
Average Volume
241,733 shares
GeoVax Labs stock logo

11. GeoVax Labs NASDAQ:GOVX

$1.54 0.00 (0.00%)
As of 03/14/2025 04:00 PM Eastern

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax Labs

Market Capitalization
$14.53 million
Consensus Rating
Buy
Consensus Price Target
$14.20 (+822.1% Upside)
Volume
556,296 shares
Average Volume
658,957 shares
Today's Range
$1.50
$1.62
Remove Ads
Nkarta stock logo

12. Nkarta NASDAQ:NKTX

$1.66 -0.06 (-3.49%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$1.69 +0.03 (+1.81%)
As of 03/14/2025 06:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about Nkarta

Market Capitalization
$121.38 million
P/E Ratio
-0.88
Consensus Rating
Buy
Consensus Price Target
$15.00 (+803.6% Upside)
Volume
1.19 million shares
Average Volume
1.04 million shares
Rezolve AI stock logo

13. Rezolve AI NASDAQ:RZLV

$1.87 +0.23 (+14.02%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$1.86 -0.01 (-0.75%)
As of 03/14/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rezolve Ai Ltd. operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$321.98 million
Consensus Rating
Buy
Consensus Price Target
$6.40 (+242.2% Upside)
Volume
2.93 million shares
Average Volume
5.44 million shares
Today's Range
$1.70
$1.92
Cardiol Therapeutics stock logo

14. Cardiol Therapeutics NASDAQ:CRDL

$1.13 -0.02 (-1.74%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$1.07 -0.06 (-5.66%)
As of 03/14/2025 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol Therapeutics

Market Capitalization
$93.35 million
P/E Ratio
-2.90
Consensus Rating
Buy
Consensus Price Target
$8.40 (+643.4% Upside)
Volume
157,716 shares
Average Volume
390,082 shares
Reviva Pharmaceuticals stock logo

15. Reviva Pharmaceuticals NASDAQ:RVPH

$1.11 +0.07 (+6.73%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$1.10 -0.01 (-0.45%)
As of 03/14/2025 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$37.12 million
P/E Ratio
-1.00
Consensus Rating
Buy
Consensus Price Target
$11.40 (+927.0% Upside)
Volume
765,839 shares
Average Volume
1.07 million shares
Immunic stock logo

16. Immunic NASDAQ:IMUX

$1.15 +0.03 (+2.68%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$1.14 -0.01 (-1.30%)
As of 03/14/2025 05:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$100.89 million
P/E Ratio
-0.93
Consensus Rating
Buy
Consensus Price Target
$12.67 (+1,001.4% Upside)
Volume
534,219 shares
Average Volume
924,680 shares
Remove Ads
Aclaris Therapeutics stock logo

17. Aclaris Therapeutics NASDAQ:ACRS

$1.56 0.00 (0.00%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$1.56 +0.00 (+0.32%)
As of 03/14/2025 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris Therapeutics

Market Capitalization
$168.35 million
P/E Ratio
-3.00
Consensus Rating
Buy
Consensus Price Target
$11.67 (+647.9% Upside)
Volume
945,317 shares
Average Volume
1.15 million shares
Full House Resorts stock logo

18. Full House Resorts NASDAQ:FLL

$4.03 -0.13 (-3.13%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$4.03 0.00 (-0.12%)
As of 03/14/2025 04:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Full House Resorts, Inc owns, leases, operates, develops, manages, and invests in casinos, and related hospitality and entertainment facilities in the United States. More about Full House Resorts

Market Capitalization
$143.47 million
P/E Ratio
-3.42
Consensus Rating
Buy
Consensus Price Target
$6.33 (+57.2% Upside)
Volume
130,340 shares
Average Volume
121,224 shares
Amprius Technologies stock logo

19. Amprius Technologies NYSE:AMPX

$2.04 +0.25 (+13.69%)
Closing price 03/14/2025 03:58 PM Eastern
Extended Trading
$2.04 +0.00 (+0.25%)
As of 03/14/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Amprius Technologies, Inc produces and sells ultra-high energy density lithium-ion batteries for mobility applications. The company offers silicon nanowire anode batteries. More about Amprius Technologies

Market Capitalization
$215.38 million
P/E Ratio
-4.52
Consensus Rating
Buy
Consensus Price Target
$9.29 (+356.3% Upside)
Volume
2.24 million shares
Average Volume
1.86 million shares
Alumis stock logo

20. Alumis NASDAQ:ALMS

$4.57 -0.02 (-0.44%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$4.58 +0.01 (+0.22%)
As of 03/14/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Our mission is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. More about Alumis

Market Capitalization
$215.81 million
Consensus Rating
Buy
Consensus Price Target
$26.57 (+481.4% Upside)
Volume
100,328 shares
Average Volume
171,654 shares
Today's Range
$4.55
$4.93
Clene stock logo

21. Clene NASDAQ:CLNN

$4.43 +0.06 (+1.37%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$4.47 +0.04 (+1.02%)
As of 03/14/2025 05:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Clene Inc, a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. More about Clene

Market Capitalization
$36.88 million
P/E Ratio
-0.84
Consensus Rating
Buy
Consensus Price Target
$55.25 (+1,147.2% Upside)
Volume
18,813 shares
Average Volume
76,410 shares
Corvus Pharmaceuticals stock logo

22. Corvus Pharmaceuticals NASDAQ:CRVS

$4.52 +0.02 (+0.44%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$4.58 +0.06 (+1.33%)
As of 03/14/2025 05:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Corvus Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, focuses on the development and commercialization of immune modulator product candidates to treat solid cancers, T cell lymphomas, autoimmune, allergic, and infectious diseases. More about Corvus Pharmaceuticals

Market Capitalization
$290.44 million
P/E Ratio
-4.86
Consensus Rating
Buy
Consensus Price Target
$12.38 (+173.8% Upside)
Volume
365,764 shares
Average Volume
556,589 shares
Immatics stock logo

23. Immatics NASDAQ:IMTX

$4.55 +0.03 (+0.66%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$4.55 0.00 (0.00%)
As of 03/14/2025 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. More about Immatics

Market Capitalization
$543.07 million
P/E Ratio
-6.89
Consensus Rating
Buy
Consensus Price Target
$16.67 (+266.3% Upside)
Volume
393,358 shares
Average Volume
587,493 shares
Western Copper & Gold stock logo

24. Western Copper & Gold NYSE:WRN

$1.03 -0.03 (-2.36%)
As of 03/14/2025 03:59 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$210.34 million
P/E Ratio
-51.75
Consensus Rating
Buy
Consensus Price Target
$4.25 (+310.6% Upside)
Volume
132,861 shares
Average Volume
305,885 shares
Genelux stock logo

25. Genelux NASDAQ:GNLX

$3.40 -0.18 (-5.03%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$3.48 +0.09 (+2.50%)
As of 03/14/2025 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. More about Genelux

Market Capitalization
$117.43 million
P/E Ratio
-3.58
Consensus Rating
Buy
Consensus Price Target
$18.25 (+436.8% Upside)
Volume
150,249 shares
Average Volume
243,094 shares